TY - JOUR
AU - C. Deflorimonte
AU - V. Glissendorf
AU - J. Hofer
AU - A. Cai
AU - N. Iannella
AU - J. O. Boateng
AU - G. Carter
AU - K. A. Saia
AU - H. E. Jones
AU - E. M. Wachman
A1 - 
AD - From the Department of Pediatrics, Boston Medical Center, Boston, MA (CD, NI, JOB, EMW); Boston University School of Public Health, Boston, MA (VG); Boston University Chobanian and Avedisian School of Medicine, Boston, MA (JH, AC); UNC Horizons and Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Carrboro, NC (GC, HEJ); and Department of Obstetrics and Gynecology, Boston Medical Center, Boston, MA (KAS).
AN - 37934548
BT - J Addict Med
C5 - Opioids & Substance Use; Healthcare Disparities
CP - 6
DA - Nov-Dec 01
DO - 10.1097/adm.0000000000001225
DP - NLM
ET - 20230920
IS - 6
JF - J Addict Med
LA - eng
PY - 2023
SN - 1932-0620 (Print); 1932-0620
SP - 736
EP - 738+
ST - National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders
T1 - National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders
T2 - J Addict Med
TI - National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders
U1 - Opioids & Substance Use; Healthcare Disparities
U3 - 10.1097/adm.0000000000001225
VL - 17
VO - 1932-0620 (Print); 1932-0620
Y1 - 2023
ER -